4.4 Review

The animal trypanosomiases and their chemotherapy: a review

期刊

PARASITOLOGY
卷 143, 期 14, 页码 1862-1889

出版社

CAMBRIDGE UNIV PRESS
DOI: 10.1017/S0031182016001268

关键词

animal trypanosomiases; veterinary trypanocide; drug resistance; Trypanosoma congolense; Trypanosoma vivax; Trypanosoma brucei

资金

  1. BBSRC [BB/N007999/1, BB/N007492/1]
  2. Global Alliance for Livestock Veterinary Medicines
  3. UKAid (Department for International Development, UK Government)
  4. Bill & Melinda Gates Foundation [UCE-R50A0571, GAL/0003/0001]
  5. Wellcome Trust through core grant [104111/Z/14/Z]
  6. core grant from BBSRC
  7. BBSRC [BB/N007492/1, BB/N007999/1] Funding Source: UKRI
  8. Biotechnology and Biological Sciences Research Council [BB/N007492/1, BB/N007999/1] Funding Source: researchfish

向作者/读者索取更多资源

Pathogenic animal trypanosomes affecting livestock have represented a major constraint to agricultural development in Africa for centuries, and their negative economic impact is increasing in South America and Asia. Chemotherapy and chemoprophylaxis represent the main means of control. However, research into new trypanocides has remained inadequate for decades, leading to a situation where the few compounds available are losing efficacy due to the emergence of drug-resistant parasites. In this review, we provide a comprehensive overview of the current options available for the treatment and prophylaxis of the animal trypanosomiases, with a special focus on the problem of resistance. The key issues surrounding the main economically important animal trypanosome species and the diseases they cause are also presented. As new investment becomes available to develop improved tools to control the animal trypanosomiases, we stress that efforts should be directed towards a better understanding of the biology of the relevant parasite species and strains, to identify new drug targets and interrogate resistance mechanisms.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据